Proteomic analysis of metabolic, cytoskeletal and stress response proteins in human heart failure

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 1, 2012, Pages 59-71

  Li, Weiming ^a   Rong, Rong ^b   Zhao, Sheng ^c   Zhu, Xiaoming ^a   Zhang, Ke ^d   Xiong, Xin ^e   Yu, Xueqing ^b   Cui, Qinghua ^f   Li, Shuqiang ^g   Chen, Li ^h   Cai, Jun ^a   Du, Jie ⁱ  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e CHONGQING MEDICAL UNIVERSITY   (China)

^f PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^g HARVARD MEDICAL SCHOOL   (United States)

^h TEXAS HEART INSTITUTE   (United States)

ⁱ CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cytoskeleton; Heart failure; Heat shock protein; Metabolism; Proteomics

Indexed keywords

HEAT SHOCK PROTEIN; PROTEOME;

ADULT; ARTICLE; CYTOSKELETON; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART FAILURE; HEART VENTRICLE; HUMAN; MALE; METABOLISM; METHODOLOGY; MICROARRAY ANALYSIS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEOMICS;

ADULT; CYTOSKELETON; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART FAILURE; HEART VENTRICLES; HEAT-SHOCK PROTEINS; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; MICROARRAY ANALYSIS; MIDDLE AGED; PROTEOME; PROTEOMICS;

EID: 84855167563     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01336.x     Document Type: Article

References (46)

1. Adams Jr K, Baughman K, Dec W, et al HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction-pharmacological approaches. Pharmacotherapy. 2000; 20: 495-2.
2. Stewart S, MacIntyre K, Capewell S, et al Heart failure and the aging population: an increasing burden in the 21st century? Heart. 2003; 89: 49-3.
3. Wasinger V, Cordwell S, Cerpa-Poljak A, et al Progress with gene-product mapping of the mollicutes: mycoplasma genitalium. Electrophoresis. 1995; 16: 1090-4.
4. Fink J, Aturaliya R, Davis M, et al Locate: a mouse protein subcellular localization database. Nucleic Acids Res. 2006; 34: D213-7.
5. Thomas P, Campbell M, Kejariwal A, et al Panther: a library of protein families and subfamilies indexed by function. Genome Res. 2003; 13: 2129-41.
6. Van der Heiden K, Cuhlmann S, Luong le A, et al Role of nuclear factor kappaB in cardiovascular health and disease. Clin Sci. 2010; 118: 593-5.
7. Lee HG, Chen Q, Wolfram JA, et al Cell cycle re-entry and mitochondrial defects in myc-mediated hypertrophic cardiomyopathy and heart failure. PLoS One. 2009; 4: e7172.
8. Lemke LE, Bloem LJ, Fouts R, et al Decreased p38 MAPK activity in end-stage failing human myocardium: p38 MAPK alpha is the predominant isoform expressed in human heart. J Mol Cell Cardiol. 2001; 33: 1527-40.
9. Fatma N, Kubo E, Takamura Y, et al Loss of NF-kappaB control and repression of Prdx6 gene transcription by reactive oxygen species-driven SMAD3-mediated transforming growth factor beta signaling. J Biol Chem. 2009; 284: 22758-72.
10. Janunger T, Anan I, Holmgren G, et al Heart failure caused by a novel amyloidogenic mutation of the transthyretin gene: ATTR Ala45Ser. Amyloid. 2000; 7: 137-40.
11. Fiedler U, Reiss Y, Scharpfenecker M, et al Angiopoietin-2 sensitizes endothelial cells to TNF-alpha and has a crucial role in the induction of inflammation. Nat Med. 2006; 12: 235-9.
12. Niizeki T, Takeishi Y, Arimoto T, et al Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients. J Card Fail. 2007; 13: 120-7.
13. Lam L, Arthur J, Semsarian C. Proteome map of the normal murine ventricular myocardium. Proteomics. 2007; 7: 3629-33.
14. Fountoulakis M, Soumaka E, Rapti K, et al Alterations in the heart mitochondrial proteome in a desmin null heart failure model. J Mol Cell Cardiol. 2005; 38: 461-74.
15. Wei Y, Cui C, Lainscak M, et al Type-specific dysregulation of matrix metalloproteinases and their tissue inhibitors in end-stage heart failure patients. J Cell Mol Med. 2010; 15: 773-82.
16. Chen JF, Murchison EP, Tang R, et al Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proc Natl Acad Sci USA. 2008; 105: 2111-6.
17. Schipper ME, van Kuik J, de Jonge N, et al Changes in regulatory microRNA expression in myocardium of heart failure patients on left ventricular assist device support. J Heart Lung Transplant. 2008; 27: 1282-5.
18. Predmore JM, Wang P, Davis F, et al Ubiquitin proteasome dysfunction in human hypertrophic and dilated cardiomyopathies. Circulation. 2010; 121: 997-1004.
19. Heinke M, Wheeler C, Chang D, et al Protein changes observed in pacing-induced heart failure using two-dimensional electrophoresis. Electrophoresis. 1998; 19: 2021-30.
20. Sawicki G, Jugdutt B. Detection of regional changes in protein levels in the in vivo canine model of acute heart failure following ischemia-reperfusion injury: functional proteomics studies. Proteomics. 2004; 4: 2195-202.
21. Chu G, Kerr J, Mitton B, et al Proteomic analysis of hyperdynamic mouse hearts with enhanced sarcoplasmic reticulum calcium cycling. FASEB J. 2004: 04: 1725-7.
22. Jüllig M, Hickey A, Chai C, et al Is the failing heart out of fuel or a worn engine running rich? A study of mitochondria in old spontaneously hypertensive rats. Proteomics. 2008; 8: 2556-72.
23. Weekes J, Wheeler C, Yan J, et al Bovine dilated cardiomyopathy: proteomic analysis of an animal model of human dilated cardiomyopathy. Electrophoresis. 1999; 20: 898-906.
24. Ashrafian H, Redwood C, Blair E, et al Hypertrophic cardiomyopathy: a paradigm for myocardial energy depletion. Trends Genet. 2003; 19: 263-8.
25. Jin X, Xia L, Wang L, et al Differential protein expression in hypertrophic heart with and without hypertension in spontaneously hypertensive rats. Proteomics. 2006; 6: 1948-56.
26. Ogut O, Brozovich F. The potential role of MLC phosphatase and MAPK signalling in the pathogenesis of vascular dysfunction in heart failure. J Cell Mol Med. 2008; 12: 2158-64.
27. Seguchi O, Takashima S, Yamazaki S, et al A cardiac myosin light chain kinase regulates sarcomere assembly in the vertebrate heart. J Clin Invest. 2007; 117: 2812-24.
28. Kazmierczak K, Xu Y, Jones M, et al The role of the n-terminus of the myosin essential light chain in cardiac muscle contraction. J Mol Biol. 2009; 387: 706-25.
29. Corbett J, Why H, Wheeler C, et al Cardiac protein abnormalities in dilated cardiomyopathy detected by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis. 1998; 19: 2031-42.
30. White M, Cordwell S, McCarron H, et al Proteomics of ischemia/reperfusion injury in rabbit myocardium reveals alterations to proteins of essential functional systems. Proteomics. 2005; 5: 1395-410.
31. 2+-sensitivity of force is enhanced in failing human hearts. Cardiovasc Res. 2003; 57: 505-14.
32. Roopnarine O. Mechanical defects of muscle fibers with myosin light chain mutants that cause cardiomyopathy. Biophys J. 2003; 84: 2440-9.
33. Bhavsar P, Brand N, Yacoub M, et al Isolation and characterization of the human cardiac troponin I gene (TNNI3). Genomics. 1996; 35: 11-23.
34. Fan G, Chu G, Mitton B, et al Small heat-shock protein hsp20 phosphorylation inhibits beta-agonist-induced cardiac apoptosis. Circ Res. 2004; 94: 1474-82.
35. Haslbeck M. sHsps and their role in the chaperone network. Cell Mol Life Sci. 2002; 59: 1649-57.
36. Martin J, Mestril R, Hilal-Dandan R, et al Small heat shock proteins and protection against ischemic injury in cardiac myocytes. Circulation. 1997; 96: 4343-8.
37. Chi N, Karliner J. Molecular determinants of responses to myocardial ischemia/reperfusion injury: focus on hypoxia-inducible and heat shock factors. Cardiovasc Res. 2004; 61: 437-47.
38. Knowlton A, Kapadia S, Torre-Amione G, et al Differential expression of heat shock proteins in normal and failing human hearts. J Mol Cell Cardiol. 1998; 30: 811-8.
39. Dohke T, Wada A, Isono T, et al Proteomic analysis reveals significant alternations of cardiac small heat shock protein expression in congestive heart failure. J Cardiac Fail. 2006; 12: 77-84.
40. Webster K. Serine phosphorylation and suppression of apoptosis by the small heat shock protein αB-crystallin. Circ Res. 2003; 92: 130-2.
41. Banfi C, Brioschi M, Wait R, et al Proteomic analysis of membrane microdomains derived from both failing and non-failing human hearts. Proteomics. 2006; 6: 1976-88.
42. Vicart P, Caron A, Guicheney P, et al A missense mutation in the aB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet. 1998; 20: 92-5.
43. Wang X, Klevitsky R, Huang W, et al AlphaB-crystallin modulates protein aggregation of abnormal desmin. Circ Res. 2003; 93: 998-1005.
44. D'Sa-Eipper C, Subramanian T, Chinnadurai G. Bfl-1, a bcl-2 homologue, suppresses p53-induced apoptosis and exhibits potent cooperative transforming activity. Cancer Res. 1996; 56: 3879-82.
45. Zong WX, Edelstein LC, Chen C, et al The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kB that blocks TNF-α-induced apoptosis. Genes Dev. 1999; 13: 382-7.
46. Zhang D, Mott JL, Farrar P, et al Mitochondrial DNA mutations activate the mitochondrial apoptotic pathway and cause dilated cardiomyopathy. Cardiovasc Res. 2003; 57: 147-57.